In­fec­tious dis­ease biotech Blue­jay rais­es $182M for he­pati­tis tri­als

Last year
Financing
Startups

Up­dat­ed: Take­da to re­vamp in mul­ti­year quest, piv­ots CAR-NK ther­a­py from can­cer to au­toim­mune

Last year
Pharma

Cy­tomX shares plum­met as Am­gen-part­nered can­cer drug yields jum­bled Phase 1 da­ta

Last year
R&D

At­tovia reels in $105M from crossover in­vestors to run mul­ti­ple tri­als of I&I bi­o­log­ics

Last year
Financing
Startups

No­vo Nordisk sees more to GLP-1's fu­ture in $600M pact with Flag­ship's Metaphore

Last year
Startups
Deals

Aard­vark nabs $85M to tar­get hunger, not ap­petite, as it eyes 2026 NDA fil­ing

Last year
Financing
Startups

Dan­ish biotech nabs No­vo Hold­ings sup­port in seed round for com­ple­ment plat­form

Last year
Financing

Law­mak­ers con­sid­er lim­it­ing how long ex­ist­ing WuXi con­tracts can con­tin­ue

Last year
Deals
China

House pan­el marks up bill to re­quire PBMs to use a flat fee in Medicare

Last year
Pharma
FDA+

Af­ter eight years with Sanofi, Frank Nes­tle de­parts as CSO, glob­al head of re­search

Last year
People

In­side CVS Care­mark’s move that broke Hu­mi­ra’s hold on the mar­ket

Last year
Pharma
Health Tech

Te­va to close ad­di­tion­al man­u­fac­tur­ing sites as it en­ters next phase of 'piv­ot to growth'

Last year
Pharma
Manufacturing

Sen­ate ap­pro­pri­a­tors ques­tion FDA com­mis­sion­er on H5N1 virus prep

Last year
FDA+

BeiGene ear­marks $74M to build fourth fa­cil­i­ty in Chi­na

Last year
China
Manufacturing

Pharm­ing ends deal with Or­chard; Seres con­sid­ers cost-cut­ting

Last year
News Briefing

Mar­i­nus lays off 20% of work­force, cuts costs to stay afloat

Last year
People

'Big­ger, faster, bet­ter': Iso­mor­phic, Deep­Mind un­veil Al­phaFold 3, go­ing be­yond pro­tein pre­dic­tions

Last year
R&D
AI

Af­ter CRISPR ba­by scan­dal shut down work for years, Chi­na gene edit­ing com­pa­nies are restart­ing clin­i­cal tri­als

Last year
China
Cell/Gene Tx

Em­ploy­ers are pulling back from pro­vid­ing men­tal health ben­e­fits, Talk­space warns

Last year
Health Tech

Te­va’s an­tipsy­chot­ic as­set pass­es Phase 3 test in schiz­o­phre­nia

Last year
R&D

As­traZeneca pulls Covid-19 vac­cine glob­al­ly as the phar­ma sees 'no fu­ture com­mer­cial de­mand'

Last year
R&D
Pharma

Os­car is wind­ing down its small em­ploy­er health plans with Cigna

Last year
Startups
Health Tech

Pa­tient dies in Pfiz­er’s Phase 2 Duchenne mus­cu­lar dy­s­tro­phy tri­al

Last year
Pharma

White House un­veils long-await­ed pol­i­cy on over­see­ing re­search of con­cern

Last year
Pharma
FDA+
First page Previous page 160161162163164165166 Next page Last page
A service from the Financial Times